Richard Bergenstal, MD
Endocrinology, Diabetes & Metabolism · St Louis Park, MNNPI 1669459061
Payments from drug & device makers
Across 736 payments — averaging $5490.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1.4M
- Eli Lilly$1.2M
- Medtronic$733K
- Dexcom, Inc.$277K
- Sanofi US Services Inc.$176K
- Novo Nordisk AS$78K
- plus $192K from 15 others
Across 15 payments — averaging $2912.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$34K
- Sanofi-aventis U.S. LLC$5K
- Novartis$2K
- Novo Nordisk AS$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 219 | $1,410,003 |
| Eli Lilly | 96 | $1,175,448 |
| Medtronic(2 entities) | 72 | $733,384 |
| Dexcom, Inc. | 30 | $276,561 |
| Sanofi US Services Inc. | 165 | $175,947 |
| Novo Nordisk AS | 31 | $77,801 |
| Roche Diabetes Care GmbH | 20 | $44,879 |
| Sanofi | 10 | $36,679 |
| Sanofi-aventis U.S. LLC | 30 | $29,100 |
| Novo Nordisk | 8 | $19,346 |
| Vertex | 18 | $17,117 |
| Zealand Pharma US, Inc. | 11 | $12,396 |
| Roche Diabetes Care, Inc. | 1 | $10,768 |
| Ascensia Diabetes Care US Inc. | 9 | $5,894 |
| Cequr Corporation | 1 | $5,500 |
| Merck | 6 | $4,266 |
| Embecta Corp. | 2 | $2,273 |
| Mannkind Corporation | 4 | $1,600 |
| Boehringer Ingelheim International GmbH | 1 | $1,549 |
| Tandem Diabetes Care, Inc. | 1 | $116 |
| Lifescan, Inc. | 1 | $109 |
How this compares
$4,040,736 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.
See all endocrinology, diabetes & metabolism providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in St Louis Park
- Anders CarlsonSt Louis Park$5.6M
- Haleigh JamesSt Louis Park$1.1M
- Laura LafaveSt Louis Park$1K
- Irina BancosRochester$4.8M
- Yogish KudvaRochester$2.9M
- Marius StanRochester$2.2M
- John MorrisRochester$1.9M
- Adrian VellaRochester$1.7M
- Mabel RyderRochester$691K
- Maria CaramoriMinneapolis$685K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.